ICD-10-CM category
T80: Complications following infusion, transfusion and therapeutic injection
Codes under T80 (Complications following infusion, transfusion and therapeutic injection). A ✓ marks a billable (fully specified) code; category codes without a ✓ are not billable on their own.
| Code | Description | Billable |
|---|---|---|
| T80.0 | Air embolism following infusion, transfusion and therapeutic injection | — |
| T80.0XXA | Air embolism following infusion, transfusion and therapeutic injection, initial encounter | ✓ |
| T80.0XXD | Air embolism following infusion, transfusion and therapeutic injection, subsequent encounter | ✓ |
| T80.0XXS | Air embolism following infusion, transfusion and therapeutic injection, sequela | ✓ |
| T80.1 | Vascular complications following infusion, transfusion and therapeutic injection | — |
| T80.1XXA | Vascular complications following infusion, transfusion and therapeutic injection, initial encounter | ✓ |
| T80.1XXD | Vascular complications following infusion, transfusion and therapeutic injection, subsequent encounter | ✓ |
| T80.1XXS | Vascular complications following infusion, transfusion and therapeutic injection, sequela | ✓ |
| T80.2 | Infections following infusion, transfusion and therapeutic injection | — |
| T80.3 | ABO incompatibility reaction due to transfusion of blood or blood products | — |
| T80.4 | Rh incompatibility reaction due to transfusion of blood or blood products | — |
| T80.5 | Anaphylactic reaction due to serum | — |
| T80.6 | Other serum reactions | — |
| T80.8 | Other complications following infusion, transfusion and therapeutic injection | — |
| T80.9 | Unspecified complication following infusion, transfusion and therapeutic injection | — |
| T80.21 | Infection due to central venous catheter | — |
| T80.22 | Acute infection following transfusion, infusion, or injection of blood and blood products | — |
| T80.22XA | Acute infection following transfusion, infusion, or injection of blood and blood products, initial encounter | ✓ |
| T80.22XD | Acute infection following transfusion, infusion, or injection of blood and blood products, subsequent encounter | ✓ |
| T80.22XS | Acute infection following transfusion, infusion, or injection of blood and blood products, sequela | ✓ |
| T80.29 | Infection following other infusion, transfusion and therapeutic injection | — |
| T80.29XA | Infection following other infusion, transfusion and therapeutic injection, initial encounter | ✓ |
| T80.29XD | Infection following other infusion, transfusion and therapeutic injection, subsequent encounter | ✓ |
| T80.29XS | Infection following other infusion, transfusion and therapeutic injection, sequela | ✓ |
| T80.30 | ABO incompatibility reaction due to transfusion of blood or blood products, unspecified | — |
| T80.30XA | ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter | ✓ |
| T80.30XD | ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter | ✓ |
| T80.30XS | ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela | ✓ |
| T80.31 | ABO incompatibility with hemolytic transfusion reaction | — |
| T80.39 | Other ABO incompatibility reaction due to transfusion of blood or blood products | — |
| T80.39XA | Other ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter | ✓ |
| T80.39XD | Other ABO incompatibility reaction due to transfusion of blood or blood products, subsequent encounter | ✓ |
| T80.39XS | Other ABO incompatibility reaction due to transfusion of blood or blood products, sequela | ✓ |
| T80.40 | Rh incompatibility reaction due to transfusion of blood or blood products, unspecified | — |
| T80.40XA | Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter | ✓ |
| T80.40XD | Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter | ✓ |
| T80.40XS | Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela | ✓ |
| T80.41 | Rh incompatibility with hemolytic transfusion reaction | — |
| T80.49 | Other Rh incompatibility reaction due to transfusion of blood or blood products | — |
| T80.49XA | Other Rh incompatibility reaction due to transfusion of blood or blood products, initial encounter | ✓ |
| T80.49XD | Other Rh incompatibility reaction due to transfusion of blood or blood products, subsequent encounter | ✓ |
| T80.49XS | Other Rh incompatibility reaction due to transfusion of blood or blood products, sequela | ✓ |
| T80.51 | Anaphylactic reaction due to administration of blood and blood products | — |
| T80.51XA | Anaphylactic reaction due to administration of blood and blood products, initial encounter | ✓ |
| T80.51XD | Anaphylactic reaction due to administration of blood and blood products, subsequent encounter | ✓ |
| T80.51XS | Anaphylactic reaction due to administration of blood and blood products, sequela | ✓ |
| T80.52 | Anaphylactic reaction due to vaccination | — |
| T80.52XA | Anaphylactic reaction due to vaccination, initial encounter | ✓ |
| T80.52XD | Anaphylactic reaction due to vaccination, subsequent encounter | ✓ |
| T80.52XS | Anaphylactic reaction due to vaccination, sequela | ✓ |
| T80.59 | Anaphylactic reaction due to other serum | — |
| T80.59XA | Anaphylactic reaction due to other serum, initial encounter | ✓ |
| T80.59XD | Anaphylactic reaction due to other serum, subsequent encounter | ✓ |
| T80.59XS | Anaphylactic reaction due to other serum, sequela | ✓ |
| T80.61 | Other serum reaction due to administration of blood and blood products | — |
| T80.61XA | Other serum reaction due to administration of blood and blood products, initial encounter | ✓ |
| T80.61XD | Other serum reaction due to administration of blood and blood products, subsequent encounter | ✓ |
| T80.61XS | Other serum reaction due to administration of blood and blood products, sequela | ✓ |
| T80.62 | Other serum reaction due to vaccination | — |
| T80.62XA | Other serum reaction due to vaccination, initial encounter | ✓ |
| T80.62XD | Other serum reaction due to vaccination, subsequent encounter | ✓ |
| T80.62XS | Other serum reaction due to vaccination, sequela | ✓ |
| T80.69 | Other serum reaction due to other serum | — |
| T80.69XA | Other serum reaction due to other serum, initial encounter | ✓ |
| T80.69XD | Other serum reaction due to other serum, subsequent encounter | ✓ |
| T80.69XS | Other serum reaction due to other serum, sequela | ✓ |
| T80.81 | Extravasation of vesicant agent | — |
| T80.82 | Complication of immune effector cellular therapy | — |
| T80.82XA | Complication of immune effector cellular therapy, initial encounter | ✓ |
| T80.82XD | Complication of immune effector cellular therapy, subsequent encounter | ✓ |
| T80.82XS | Complication of immune effector cellular therapy, sequela | ✓ |
| T80.89 | Other complications following infusion, transfusion and therapeutic injection | — |
| T80.89XA | Other complications following infusion, transfusion and therapeutic injection, initial encounter | ✓ |
| T80.89XD | Other complications following infusion, transfusion and therapeutic injection, subsequent encounter | ✓ |
| T80.89XS | Other complications following infusion, transfusion and therapeutic injection, sequela | ✓ |
| T80.90 | Unspecified complication following infusion and therapeutic injection | — |
| T80.90XA | Unspecified complication following infusion and therapeutic injection, initial encounter | ✓ |
| T80.90XD | Unspecified complication following infusion and therapeutic injection, subsequent encounter | ✓ |
| T80.90XS | Unspecified complication following infusion and therapeutic injection, sequela | ✓ |
| T80.91 | Hemolytic transfusion reaction, unspecified incompatibility | — |
| T80.92 | Unspecified transfusion reaction | — |
| T80.92XA | Unspecified transfusion reaction, initial encounter | ✓ |
| T80.92XD | Unspecified transfusion reaction, subsequent encounter | ✓ |
| T80.92XS | Unspecified transfusion reaction, sequela | ✓ |
| T80.211 | Bloodstream infection due to central venous catheter | — |
| T80.211A | Bloodstream infection due to central venous catheter, initial encounter | ✓ |
| T80.211D | Bloodstream infection due to central venous catheter, subsequent encounter | ✓ |
| T80.211S | Bloodstream infection due to central venous catheter, sequela | ✓ |
| T80.212 | Local infection due to central venous catheter | — |
| T80.212A | Local infection due to central venous catheter, initial encounter | ✓ |
| T80.212D | Local infection due to central venous catheter, subsequent encounter | ✓ |
| T80.212S | Local infection due to central venous catheter, sequela | ✓ |
| T80.218 | Other infection due to central venous catheter | — |
| T80.218A | Other infection due to central venous catheter, initial encounter | ✓ |
| T80.218D | Other infection due to central venous catheter, subsequent encounter | ✓ |
| T80.218S | Other infection due to central venous catheter, sequela | ✓ |
| T80.219 | Unspecified infection due to central venous catheter | — |
| T80.219A | Unspecified infection due to central venous catheter, initial encounter | ✓ |
| T80.219D | Unspecified infection due to central venous catheter, subsequent encounter | ✓ |
| T80.219S | Unspecified infection due to central venous catheter, sequela | ✓ |
| T80.310 | ABO incompatibility with acute hemolytic transfusion reaction | — |
| T80.310A | ABO incompatibility with acute hemolytic transfusion reaction, initial encounter | ✓ |
| T80.310D | ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter | ✓ |
| T80.310S | ABO incompatibility with acute hemolytic transfusion reaction, sequela | ✓ |
| T80.311 | ABO incompatibility with delayed hemolytic transfusion reaction | — |
| T80.311A | ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter | ✓ |
| T80.311D | ABO incompatibility with delayed hemolytic transfusion reaction, subsequent encounter | ✓ |
| T80.311S | ABO incompatibility with delayed hemolytic transfusion reaction, sequela | ✓ |
| T80.319 | ABO incompatibility with hemolytic transfusion reaction, unspecified | — |
| T80.319A | ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter | ✓ |
| T80.319D | ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter | ✓ |
| T80.319S | ABO incompatibility with hemolytic transfusion reaction, unspecified, sequela | ✓ |
| T80.410 | Rh incompatibility with acute hemolytic transfusion reaction | — |
| T80.410A | Rh incompatibility with acute hemolytic transfusion reaction, initial encounter | ✓ |
| T80.410D | Rh incompatibility with acute hemolytic transfusion reaction, subsequent encounter | ✓ |
| T80.410S | Rh incompatibility with acute hemolytic transfusion reaction, sequela | ✓ |
| T80.411 | Rh incompatibility with delayed hemolytic transfusion reaction | — |
| T80.411A | Rh incompatibility with delayed hemolytic transfusion reaction, initial encounter | ✓ |
| T80.411D | Rh incompatibility with delayed hemolytic transfusion reaction, subsequent encounter | ✓ |
| T80.411S | Rh incompatibility with delayed hemolytic transfusion reaction, sequela | ✓ |
| T80.419 | Rh incompatibility with hemolytic transfusion reaction, unspecified | — |
| T80.419A | Rh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter | ✓ |
| T80.419D | Rh incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter | ✓ |
| T80.419S | Rh incompatibility with hemolytic transfusion reaction, unspecified, sequela | ✓ |
| T80.810 | Extravasation of vesicant antineoplastic chemotherapy | — |
| T80.810A | Extravasation of vesicant antineoplastic chemotherapy, initial encounter | ✓ |
| T80.810D | Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter | ✓ |
| T80.810S | Extravasation of vesicant antineoplastic chemotherapy, sequela | ✓ |
| T80.818 | Extravasation of other vesicant agent | — |
| T80.818A | Extravasation of other vesicant agent, initial encounter | ✓ |
| T80.818D | Extravasation of other vesicant agent, subsequent encounter | ✓ |
| T80.818S | Extravasation of other vesicant agent, sequela | ✓ |
| T80.910 | Acute hemolytic transfusion reaction, unspecified incompatibility | — |
| T80.910A | Acute hemolytic transfusion reaction, unspecified incompatibility, initial encounter | ✓ |
| T80.910D | Acute hemolytic transfusion reaction, unspecified incompatibility, subsequent encounter | ✓ |
| T80.910S | Acute hemolytic transfusion reaction, unspecified incompatibility, sequela | ✓ |
| T80.911 | Delayed hemolytic transfusion reaction, unspecified incompatibility | — |
| T80.911A | Delayed hemolytic transfusion reaction, unspecified incompatibility, initial encounter | ✓ |
| T80.911D | Delayed hemolytic transfusion reaction, unspecified incompatibility, subsequent encounter | ✓ |
| T80.911S | Delayed hemolytic transfusion reaction, unspecified incompatibility, sequela | ✓ |
| T80.919 | Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed | — |
| T80.919A | Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, initial encounter | ✓ |
| T80.919D | Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, subsequent encounter | ✓ |
| T80.919S | Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, sequela | ✓ |
| T80.A | Non-ABO incompatibility reaction due to transfusion of blood or blood products | — |
| T80.A0 | Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified | — |
| T80.A0XA | Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter | ✓ |
| T80.A0XD | Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter | ✓ |
| T80.A0XS | Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela | ✓ |
| T80.A1 | Non-ABO incompatibility with hemolytic transfusion reaction | — |
| T80.A9 | Other non-ABO incompatibility reaction due to transfusion of blood or blood products | — |
| T80.A9XA | Other non-ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter | ✓ |
| T80.A9XD | Other non-ABO incompatibility reaction due to transfusion of blood or blood products, subsequent encounter | ✓ |
| T80.A9XS | Other non-ABO incompatibility reaction due to transfusion of blood or blood products, sequela | ✓ |
| T80.A10 | Non-ABO incompatibility with acute hemolytic transfusion reaction | — |
| T80.A10A | Non-ABO incompatibility with acute hemolytic transfusion reaction, initial encounter | ✓ |
| T80.A10D | Non-ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter | ✓ |
| T80.A10S | Non-ABO incompatibility with acute hemolytic transfusion reaction, sequela | ✓ |
| T80.A11 | Non-ABO incompatibility with delayed hemolytic transfusion reaction | — |
| T80.A11A | Non-ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter | ✓ |
| T80.A11D | Non-ABO incompatibility with delayed hemolytic transfusion reaction, subsequent encounter | ✓ |
| T80.A11S | Non-ABO incompatibility with delayed hemolytic transfusion reaction, sequela | ✓ |
| T80.A19 | Non-ABO incompatibility with hemolytic transfusion reaction, unspecified | — |
| T80.A19A | Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter | ✓ |
| T80.A19D | Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter | ✓ |
| T80.A19S | Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, sequela | ✓ |
More free billing tools: all ICD-10 categories · ICD-10 search · denial codes · Medicare fees
Informational only, not coding or medical advice. Verify against the official ICD-10-CM (FY2026) and your payer's guidelines.
Code the diagnosis right
Join providers across the country delivering modern virtual care with CareNiva. Free to start, ready in minutes.
100% Satisfaction Guaranteed — try it risk-free